| Bioactivity | Sebetralstat (KVD900) is a plasma kallikrein inhibitor (WO2016083820). Sebetralstat can be used for the research of metabolic diseases[1]. | ||||||||||||
| Target | Plasma Kallikrein | ||||||||||||
| Invitro | Sebetralstat is a plasma kallikrein inhibitor[1]. | ||||||||||||
| Name | Sebetralstat | ||||||||||||
| CAS | 1933514-13-6 | ||||||||||||
| Formula | C26H26FN5O4 | ||||||||||||
| Molar Mass | 491.51 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. WO2016083820 |
Sebetralstat
CAS: 1933514-13-6 F: C26H26FN5O4 W: 491.51
Sebetralstat (KVD900) is a plasma kallikrein inhibitor (WO2016083820). Sebetralstat can be used for the research of meta
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.